Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate
2. Carbetapentane
3. Carbetapentane 1,5-napthalenedisulfonate (2:1)
4. Carbetapentane 2,6-napthalenedisulfonate (2:1)
5. Carbetapentane Tannate
6. Pentoxyverine
1. Pentoxyverine Citrate
2. 23142-01-0
3. Loucarbate
4. Toclase
5. Pentoxiverine Citrate
6. Carbetapentane (citrate)
7. Carbetapentane Citrate Salt
8. 4sh0mfj5hj
9. Nsc-757833
10. Pentoxyverine Hydrogen Citrate
11. Ethanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester) Citrate
12. Toclase Citrate
13. 2-(2-(diethylamino)ethoxy)ethyl 1-phenylcyclopentanecarboxylate Citrate (1:1)
14. Cyclopentanecarboxylic Acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl Ester, Citrate (1:1)
15. Carbetapentone Citrate
16. 2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate Citrate
17. Carbetapentane Citrate [nf]
18. Sr-01000075435
19. Einecs 245-449-5
20. Unii-4sh0mfj5hj
21. Astomatop (tn)
22. 2-(2-(diethylamino)ethoxy)ethyl 1-phenylcyclopentanecarboxylate 2-hydroxypropane-1,2,3-tricarboxylate
23. Prestwick_748
24. Caretapentane Citrate
25. Mfcd00055697
26. Lopac-c-4662
27. Pentoxyverine Citrate,(s)
28. 2-(2(diethylamino)ethoxy)ethyl 1-phenyl-cyclopentanecarboxylate Citrate (1:1)
29. 2-(2-(diethylamino)ethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate Dihydrogen Citrate
30. Mls000859895
31. Mls002207180
32. Schembl160096
33. Spectrum1501129
34. Pentoxyverine Citrate (jp17)
35. Chembl1256696
36. Chebi:31352
37. Hms501b18
38. Dtxsid10177717
39. Hms1569m15
40. Hms1921h13
41. Hms2092f03
42. Hms2096m15
43. Hms2233b06
44. Hms3260p08
45. Hms3266a18
46. Hms3370a07
47. Hms3411m11
48. Hms3675m11
49. Hms3713m15
50. Pharmakon1600-01501129
51. Carbetapentane Citrate [mi]
52. Pentoxyverine Citrate [jan]
53. Bcp13538
54. Ex-a4861
55. Hy-b1055
56. Tox21_500313
57. 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate Citrate
58. Ccg-39029
59. Nsc757833
60. Carbetapentane Citrate [vandf]
61. Pentoxyverine Citrate [mart.]
62. Akos015899622
63. Pentoxyverine Citrate [who-dd]
64. Cs-4577
65. Lp00313
66. Nsc 757833
67. 1-phenyl-cyclopentanecarboxylic Acid 2-[2-(diethylamino)ethoxy]ethyl Ester Citrate
68. Ncgc00016128-01
69. Ncgc00016128-02
70. Ncgc00016128-03
71. Ncgc00016128-04
72. Ncgc00016128-05
73. Ncgc00017090-01
74. Ncgc00093760-01
75. Ncgc00093760-02
76. Ncgc00093760-03
77. Ncgc00260998-01
78. Ac-19682
79. Ac-36723
80. As-35372
81. Bp166189
82. Diethyl(2-(2-((1-phenylcyclopentyl)formyloxy)ethoxy)ethyl)ammoniumdihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
83. Cas-23142-01-0
84. Db-046085
85. Eu-0100313
86. Ft-0630493
87. C 4662
88. D01260
89. 077p236
90. A839013
91. Pentoxyverine Hydrogen Citrate [ep Monograph]
92. Sr-01000075435-1
93. Sr-01000075435-3
94. Sr-01000075435-5
95. Sr-01000075435-7
96. Sr-01000075435-8
97. W-107426
98. Q27260431
99. Sr-01000075435-11
100. 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentane Carboxylate Citrate
101. 1-phenylcyclopentanecarboxylic Acid 2-(2-diethylaminoethoxy)ethyl Ester Citrate
102. 2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate; 2-oxidanylpropane-1,2,3-tricarboxylic Acid
103. 2-hydroxypropane-1,2,3-tricarboxylic Acid; 1-phenyl-1-cyclopentanecarboxylic Acid 2-[2-(diethylamino)ethoxy]ethyl Ester
Molecular Weight | 525.6 g/mol |
---|---|
Molecular Formula | C26H39NO10 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 16 |
Exact Mass | 525.25739644 g/mol |
Monoisotopic Mass | 525.25739644 g/mol |
Topological Polar Surface Area | 171 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 583 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35912
Submission : 2021-05-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3712
Submission : 1980-01-30
Status : Inactive
Type : II
Registration Number : 225MF10025
Registrant's Address : 2-10-50 Mukaimachi, Furukawa-cho, Hida-shi, Gifu Prefecture
Initial Date of Registration : 2013-02-13
Latest Date of Registration : --
Registration Number : 221MF10228
Registrant's Address : 2-10-50 Mukaimachi, Furukawa-cho, Hida-shi, Gifu Prefecture
Initial Date of Registration : 2009-10-19
Latest Date of Registration : --
Japanese Pharmacopoeia Pentoxyverine Citrate
Registration Number : 221MF10228
Registrant's Address : 2-10-50 Mukaimachi, Furukawa-cho, Hida-shi, Gifu Prefecture
Initial Date of Registration : 2009-10-19
Latest Date of Registration : 2009-10-19
Japanese Pharmacopoeia Pentoxyverine Citrate
Registration Number : 225MF10025
Registrant's Address : 2-10-50 Mukaimachi, Furukawa-cho, Hida-shi, Gifu Prefecture
Initial Date of Registration : 2013-02-13
Latest Date of Registration : 2016-05-06
Regulatory Info :
Registration Country : South Korea
Acetaminophen/Paracetamol; Chlorpheniramine; Carbetapentane Citrate; C13639; Guaifenesin; Caffeine
Brand Name : Easy Cold Syrup
Dosage Form : Syrup
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Market Place
ABOUT THIS PAGE
A Pentoxiverine citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pentoxiverine citrate, including repackagers and relabelers. The FDA regulates Pentoxiverine citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pentoxiverine citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pentoxiverine citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pentoxiverine citrate supplier is an individual or a company that provides Pentoxiverine citrate active pharmaceutical ingredient (API) or Pentoxiverine citrate finished formulations upon request. The Pentoxiverine citrate suppliers may include Pentoxiverine citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Pentoxiverine citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pentoxiverine citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Pentoxiverine citrate active pharmaceutical ingredient (API) in detail. Different forms of Pentoxiverine citrate DMFs exist exist since differing nations have different regulations, such as Pentoxiverine citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pentoxiverine citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Pentoxiverine citrate USDMF includes data on Pentoxiverine citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pentoxiverine citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pentoxiverine citrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pentoxiverine citrate Drug Master File in Japan (Pentoxiverine citrate JDMF) empowers Pentoxiverine citrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pentoxiverine citrate JDMF during the approval evaluation for pharmaceutical products. At the time of Pentoxiverine citrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pentoxiverine citrate suppliers with JDMF on PharmaCompass.
Pentoxiverine citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pentoxiverine citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pentoxiverine citrate GMP manufacturer or Pentoxiverine citrate GMP API supplier for your needs.
A Pentoxiverine citrate CoA (Certificate of Analysis) is a formal document that attests to Pentoxiverine citrate's compliance with Pentoxiverine citrate specifications and serves as a tool for batch-level quality control.
Pentoxiverine citrate CoA mostly includes findings from lab analyses of a specific batch. For each Pentoxiverine citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pentoxiverine citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Pentoxiverine citrate EP), Pentoxiverine citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pentoxiverine citrate USP).
LOOKING FOR A SUPPLIER?